Entecavir (Baraclude®)

All Wales Medicines Strategy Group (AWMSG)
Record ID 32012000343
English
Authors' recommendations: Entecavir (Baraclude®) is recommended as an option for use within NHS Wales for the treatment of chronic hepatitis B virus infection in adults with decompensated liver disease. Oral solution should only be used in circumstances where the tablet form is not a clinical option. Treatment should normally be initiated following dialogue with a specialist liver unit. AWMSG is of the opinion that entecavir (Baraclude®) is suitable for specialist only prescribing within NHS Wales for the above indication.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Wales, United Kingdom
MeSH Terms
  • Humans
  • Guanine
  • Antiviral Agents
  • Hepatitis B, Chronic
Contact
Organisation Name: All Wales Medicines Strategy Group
Contact Address: All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX
Contact Name: AWTTC@wales.nhs.uk
Contact Email: AWTTC@wales.nhs.uk
Copyright: AWTTC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.